US$ 25.50
benzo a pyrene phase 2 glutathione s transferase Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase Benzo[a]pyrene (B[a]P) bioactivation. Major mechanism
Description
Rochman et al., 2014)
![benzo a pyrene phase 2 glutathione s transferase Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase Benzo[a]pyrene (B[a]P) bioactivation. Major mechanism](https://www.researchgate.net/publication/328070467/figure/fig1/AS:677997531123723@1538658616288/Benzoapyrene-BaP-bioactivation-Major-mechanism-of-DNA-binding-by-BaP-a.png)
[DOI] [PMC free article] [PubMed] [Google Scholar] 113.Giraud, A
![benzo a pyrene phase 2 glutathione s transferase Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase Benzo[a]pyrene (B[a]P) bioactivation. Major mechanism](https://www.researchgate.net/profile/Daniel-Schlenk-2/publication/277687440/figure/fig3/AS:669067891453961@1536529624491/Biotransformation-pathway-of-benzo-a-pyrene-BaP.png)
Antibody patterns Across multiple antibodies, patterns of association with NHL risk were assessed using a weighted score (EBVAb score): where i is the log-odds of antibody i and Ab ij is the serostatus of the individual j for antibody i , for each study participant j across n antibodies
![benzo a pyrene phase 2 glutathione s transferase Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase Benzo[a]pyrene (B[a]P) bioactivation. Major mechanism](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad6/9181839/d85b749be8ca/ijms-23-06348-g004.jpg)
Utilisez les spcifications visibles, lemballage et les documents de lot disponibles, puis consignez les conditions de rception et de stockage dans le dossier de recherche